OncoCyte ROE 2014-2025 | OCX
Current and historical return on equity (ROE) values for OncoCyte (OCX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OncoCyte ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.06B | $0.01B | -761.29% |
| 2024-12-31 | $-0.06B | $-0.01B | -739.39% |
| 2024-09-30 | $-0.04B | $0.01B | -270.77% |
| 2024-06-30 | $-0.04B | $0.02B | -163.44% |
| 2024-03-31 | $-0.04B | $0.01B | -143.86% |
| 2023-12-31 | $-0.03B | $0.02B | -82.86% |
| 2023-09-30 | $-0.06B | $0.04B | -148.05% |
| 2023-06-30 | $-0.06B | $0.04B | -124.35% |
| 2023-03-31 | $-0.06B | $0.04B | -103.45% |
| 2022-12-31 | $-0.07B | $0.03B | -116.33% |
| 2022-09-30 | $-0.06B | $0.08B | -90.78% |
| 2022-06-30 | $-0.07B | $0.08B | -89.47% |
| 2022-03-31 | $-0.07B | $0.06B | -86.42% |
| 2021-12-31 | $-0.06B | $0.07B | -68.45% |
| 2021-09-30 | $-0.03B | $0.10B | -39.77% |
| 2021-06-30 | $-0.03B | $0.10B | -38.85% |
| 2021-03-31 | $-0.03B | $0.11B | -48.37% |
| 2020-12-31 | $-0.03B | $0.03B | -82.76% |
| 2020-09-30 | $-0.03B | $0.04B | -89.51% |
| 2020-06-30 | $-0.03B | $0.04B | -87.59% |
| 2020-03-31 | $-0.03B | $0.04B | -79.39% |
| 2019-12-31 | $-0.02B | $0.03B | -66.67% |
| 2019-09-30 | $-0.02B | $0.03B | -73.08% |
| 2019-06-30 | $-0.02B | $0.03B | -81.93% |
| 2019-03-31 | $-0.02B | $0.04B | -121.43% |
| 2018-12-31 | $-0.02B | $0.00B | -251.85% |
| 2018-09-30 | $-0.02B | $0.01B | -228.57% |
| 2018-06-30 | $-0.02B | $0.01B | -285.71% |
| 2018-03-31 | $-0.02B | $0.01B | -281.48% |
| 2017-12-31 | $-0.02B | $0.00B | -296.30% |
| 2017-09-30 | $-0.02B | $0.01B | -230.30% |
| 2017-06-30 | $-0.02B | $0.01B | -157.89% |
| 2017-03-31 | $-0.01B | $0.01B | -155.56% |
| 2016-12-31 | $-0.01B | $0.01B | -141.18% |
| 2016-09-30 | $-0.01B | $0.01B | -152.94% |
| 2016-06-30 | $-0.01B | $0.00B | -228.57% |
| 2016-03-31 | $-0.01B | $0.01B | -235.29% |
| 2015-12-31 | $-0.01B | $0.01B | -320.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.088B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| Cencora (COR) | United States | $56.472B | 19.65 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| ICON (ICLR) | Ireland | $10.225B | 9.51 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.360B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |